Skip to main content
About Us
Image Credits
Contributor Info
RSS
Log In
Join
Twitter
E-Alerts
Visit StemJournal
Main menu
About
Image Credits
Contributor Info
E-Alerts
Chapters
Cellular and nuclear reprogramming
Ectoderm specification and differentiation
Endoderm specification and differentiation
Epigenetics
Genomics and proteomics
Germ cell and somatic stem cell biology in reproduction
Manufacturing
Mesoderm specification and differentiation
Niche biology, homing, and migration
Renewal
Stem cell immunology
Therapeutic prospects
Tissue engineering
Protocols
Ectoderm differentiation
Endoderm differentiation
Genome editing
Mesoderm differentiation
Pluripotent stem cells
PSC characterization
PSC genetic stability
Reprogramming
StemLabs
Stem Cell COREdinates
Core Facility Profiles
Boston Children's Hospital Human Neuron Core
Boston University Center for Regenerative Medicine iPSC Core
Columbia Stem Cell Initiative Stem Cell Core Facility
Harvard Stem Cell Institute iPS Core Facility
Stem Cell Protocols
Stem Cell Reagents
Other Resources
News & Profiles
Latest News
Stem Cell Institute Profiles
Journal Stream
Forum
Search form
Search
You are here
Home
Biblio
Author
Title
[
Type
]
Year
Filters:
Author
is
Tey, Siok-Keen
[Clear All Filters]
Journal Article
Henden AS
,
Varelias A
,
Leach J
,
Sturgeon E
,
Avery J
,
Kelly J
,
Olver S
,
Samson L
,
Hartel G
,
Durrant S
, et al.
Pegylated interferon-2α invokes graft-versus-leukemia effects in patients relapsing after allogeneic stem cell transplantation.
Blood Adv. 2019;3(20):3013-3019.
PubMed
Google Scholar
Zhou X
,
Di Stasi A
,
Tey S-K
,
Krance RA
,
Martinez C
,
Leung KS
,
Durett AG
,
Wu M-F
,
Liu H
,
Leen AM
, et al.
Long-term outcome and immune reconstitution after haploidentical stem cell transplant in recipients of allodepleted-T-cells expressing the inducible caspase-9 safety transgene.
Blood. 2014.
PubMed
Google Scholar
Tey S-K
,
Kennedy GA
,
Cromer D
,
Davenport MP
,
Walker S
,
Jones LI
,
Crough T
,
Durrant ST
,
Morton JA
,
Butler JP
, et al.
Clinical Assessment of Anti-Viral CD8+ T Cell Immune Monitoring Using QuantiFERON-CMV® Assay to Identify High Risk Allogeneic Hematopoietic Stem Cell Transplant Patients with CMV Infection Complications.
PLoS One. 2013;8(10):e74744.
PubMed
Google Scholar
Tey S-K
,
Lane SW
.
Better the cure you know: why patients with AML ≥60 years of age should be offered early allogeneic stem cell transplantation.
Blood Adv. 2021.
PubMed
Google Scholar